Insights From The New Product Planning Panel
At the end of last year, Clarion led a panel discussion entitled, Lessons From Emerging Biopharma Companies Commercializing Their First Asset at ExL Pharma’s 3rd New Product Planning (NPP) Summit. The discussion brought together senior industry executives to share their insights and best practices in new enterprise commercialization (NEC).
The panel highlighted four key themes around preparing for successful first asset commercialization:
- Understand the Market at a Fundamental Level
- Throw out the Old Commercialization Playbook
- Start Early… Like Yesterday
- Navigate the Transition from an R&D to a Commercial Company
Read a complete summary of the discussion: Lessons From Emerging Biopharma Companies Commercializing Their First Asset
Clarion is a life sciences strategy and organizational consultancy that works together with its clients to envision, craft, and enable growth through innovation and leadership. Across therapeutic categories, Clarion collaborates deeply with its clients to tackle their most complex cross-functional business challenges and decisions throughout the product and company lifecycle. With over 15 years of unparalleled experience in new product commercialization, Clarion partners with leaders in the biopharma industry to guide strategic decision-making necessary to launch a first asset or expand an existing portfolio.